An observational study in Tuberculosis and Tuberculosis, Pulmonary, sponsored by Fundació Institut Germans Trias i Pujol. Recruiting at 1 site in Spain. Per ClinicalTrials.gov, last updated 2024-11-29.
Sponsored by Fundació Institut Germans Trias i Pujol · Observational
The purpose of this screening study is to identify and screen vulnerable population in Barcelona for active pulmonary tuberculosis
If eligible and verbal consent is obtained, individuals:
319 studies on the registry are indexed under Tuberculosis, Pulmonary; 71 are open to participants now.
This study's planned enrollment of 3,000 is above the median of 300 across 83 observational studies indexed under Tuberculosis, Pulmonary.
Browse Tuberculosis, Pulmonary studies →Fundació Institut Germans Trias i Pujol is the lead sponsor of 25 studies on the registry; 9 are open to participants now.
Compared within Tuberculosis, Pulmonary, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Tuberculosis. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Individuals from populations identified as high-risk for tuberculosis in the Barcelona metropolitan area
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-Belonging to a population at high risk for tuberculosis (TB)
Exclusion Criteria:
-Not belonging to a population at high risk for tuberculosis (TB)
Individuals from vulnerable populations residing in the Barcelona metropolitan area who are at high risk of developing tuberculosis (i.e. war refugees, migrants, individuals living in socio-deprived neighborhoods)
Other: Screening for TB symptoms · Diagnostic Test: Chest X-ray
Individuals will be screened for cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks
Chest X-ray will be performed to diagnose or exclude TB
Number of individuals who screen positive for pulmonary TB symptoms
Number of individuals who screen positive for pulmonary TB symptoms (cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks)
Time frame: 1 day
Number of individuals who are diagnosed with pulmonary TB symptoms
Number of individuals who are diagnosed with pulmonary TB symptoms after referral to the hospital
Time frame: 1 month
Cost-effectiveness analysis
Cost-effectiveness analysis of the TB screening
Time frame: 1 day
Time spent during screening
Duration of each step of the screening will be analysed: duration of talk about TB, duration of waiting time before individual gets screened, duration of screening
Time frame: 1 day
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2022 (actual). Primary completion is estimated for Dec 2026, 53 months after the start.
Of 44 observational studies under Tuberculosis, Pulmonary, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 49. This study's planned 53 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fundació Institut Germans Trias i Pujol